HEXO (HEXO) Stock Price, News & Analysis

Company Overview

HEXO Corp., together with its subsidiaries, produces, markets, and sells cannabis in Canada. The company offers its adult-use and medical products under the HEXO brand name. It also provides cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brands; and cannabis products under UP Cannabis, Original Stash, and Up brand names. It has a strategic alliance with Tilray Brands, Inc. The company was formerly known as The Hydropothecary Corporation and changed its name to HEXO Corp. in August 2018. HEXO Corp. was founded in 2013 and is headquartered in Gatineau, Canada. As of June 22, 2023, HEXO Corp. operates as a subsidiary of Tilray Brands, Inc.

Key Stats

• Today's Range: $0.66 to $0.71
• 50-Day Range: $0.69 to $1.44
• 52-Week Range: $0.66 to $3.84
• Volume: 305,500 shs
• Average Volume: 880,508 shs
• Market Capitalization: $31.24 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

HEXO Stock Analysis - Frequently Asked Questions

How were HEXO's earnings last quarter?

HEXO Corp. (NYSE:HEXO) announced its earnings results on Tuesday, December, 14th. The company reported ($5.04) earnings per share for the quarter, missing the consensus estimate of ($1.12) by $3.92. The business had revenue of $39.75 million for the quarter, compared to the consensus estimate of $45.36 million. HEXO had a negative net margin of 235.33% and a negative trailing twelve-month return on equity of 74.04%.

When did HEXO's stock split?

HEXO's stock reverse split on Monday, December 19th 2022. The 1-14 reverse split was announced on Monday, December 19th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Monday, December 19th 2022. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

What other stocks do shareholders of HEXO own?

Based on aggregate information from My MarketBeat watchlists, some other companies that HEXO investors own include Aurora Cannabis (ACB), Canopy Growth (CGC), Tilray (TLRY), Organigram (OGI), Cronos Group (CRON), NVIDIA (NVDA) and Meta Platforms (META).

Company Calendar

• Last Earnings: 12/14/2021
• Today: 5/29/2025
• Fiscal Year End: 7/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Drug Manufacturers—Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: NYSE:HEXO
• CIK: 1690947
• Web: www.hexocorp.com
• Phone: (844) 406-1852
• Fax: N/A
• Employees: 1,277
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($5.2112)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$845.90 million
• Net Margins: -235.33%
• Pretax Margin: -239.21%
• Return on Equity: -74.04%
• Return on Assets: -32.51%

Debt

• Debt-to-Equity Ratio: 0.01
• Current Ratio: 0.41
• Quick Ratio: 0.24

Sales & Book Value

• Annual Sales: $146.20 million
• Price / Sales: 0.21
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $2.44 per share
• Price / Book: 0.29

Miscellaneous

• Outstanding Shares: 44,000,000
• Free Float: 41,933,000
• Market Cap: $31.24 million
• Optionable: Optionable
• Beta: 1.35